MedTrace Logo

The Clinical Study Aims to Assess the Quality of Donor Livers Using Hyperspectral Imaging.

NCT06608667 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2024-09-23

No results posted yet for this study

Summary

Based on hyperspectral imaging equipment, this project collected hyperspectral imaging data of donor livers, analyzed various parameters, investigated the detection capability of hyperspectral imaging for assessing donor liver quality, gathered patient prognosis information, examined the correlation between early postoperative complications and hyperspectral imaging data, and explored characteristic parameters for evaluating donor liver quality using hyperspectral imaging technology. The occurrence of early complications was predicted.

Conditions

  • Liver Transplantation
  • Hyperspectral Imaging

Interventions

DEVICE

The study was retrospective and did not involve the application of interventions

The study was retrospective and did not involve the application of interventions

Sponsors & Collaborators

  • First Affiliated Hospital Xi'an Jiaotong University

    lead OTHER

Principal Investigators

  • Bo Wang, MD PhD · First Affiliated Hospital Xian Jiaotong University

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-01
Primary Completion
2023-12-30
Completion
2024-06-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06608667 on ClinicalTrials.gov